Deutsch English Français

Contact

EP1058737

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1058737

EP1058737 - NOVEL FDRG PROTEIN AND NUCLEIC ACID MOLECULES AND USES THEREFOR [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 08.12.2006 Database last updated on 18.09.2024
Most recent event Tooltip	08.12.2006	Application deemed to be withdrawn	published on 10.01.2007 [2007/02]
Applicant(s)	For all designated states MILLENNIUM PHARMACEUTICALS, INC. 75 Sidney Street Cambridge Massachusetts 02139 / US
	For all designated states DANA FARBER CANCER INSTITUTE 44 Binney Street Boston Massachusetts 02115 / US
	[N/P]
Former [2000/50]	For all designated states Millennium Pharmaceuticals, Inc. 75 Sidney Street Cambridge, Massachusetts 02139 / US
	For all designated states DANA FARBER CANCER INSTITUTE 44 Binney Street Boston Massachusetts 02115 / US
Inventor(s)	01 / HOLTZMAN, Douglas, A. 76 Fairmont Street 1 Cambridge, MA 02139 / US
	02 / SPIEGELMAN, Bruce, M. 271 Waban Avenue Waban, MA 02468 / US
	03 / YOON, Clifford, Hyunsuk Apartment 10 24 Peabody Terrace Cambridge, MA 02138 / US
	[2000/50]
Representative(s)	Lock, Graham James, et al Fry Heath & Spence LLP Unit A, Faraday Court Faraday Road Crawley, West Sussex RH10 9PU / GB
	[N/P]
Former [2000/50]	Lock, Graham James, et al Fry Heath & Spence, The Old College, 53 High Street Horley, Surrey RH6 7BN / GB
Application number, filing date	99912241.9	02.03.1999
	[2000/50]
	WO1999US04548
Priority number, date	US19980033539	02.03.1998 Original published format: US 33539
	[2000/50]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO9945135
	Date:	10.09.1999
	Language:	EN
	[1999/36]
	Type:	A1 Application with search report
	No.:	EP1058737
	Date:	13.12.2000
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 10.09.1999 takes the place of the publication of the European patent application.
	[2000/50]
Search report(s)	International search report - published on:	US	10.09.1999
	(Supplementary) European search report - dispatched on:	EP	11.11.2002
Classification	IPC:	C12Q1/00, C12Q1/68	[2000/50]
	CPC:	C07K14/515 (EP); A61P3/04 (EP); A61P3/10 (EP); C07K16/22 (EP); A61K38/00 (EP)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2000/50]
Title	German:	FDRG PROTEIN UND NUKLEINSÄUREMOLEKÜLE UND IHRE VERWENDUNG	[2006/04]
	English:	NOVEL FDRG PROTEIN AND NUCLEIC ACID MOLECULES AND USES THEREFOR	[2000/50]
	French:	NOUVELLES MOLECULES FDRG DE PROTEINES ET D'ACIDE NUCLEIQUE ET UTILISATION DESDITES MOLECULES	[2000/50]
	Former [2000/50]	FDRG PROTEIN UND NUKLEISÄUREMOLEKÜLE UND IHRE VERWENDUNG
Biological material	This application mentions deposited biological material, check the file for details
Entry into regional phase	02.10.2000	National basic fee paid
	02.10.2000	Search fee paid
	02.10.2000	Designation fee(s) paid
	02.10.2000	Examination fee paid
Examination procedure	01.10.1999	Request for preliminary examination filed International Preliminary Examining Authority: US
	02.10.2000	Examination requested [2000/50]
	09.10.2000	Amendment by applicant (claims and/or description)
	02.10.2003	Despatch of a communication from the examining division (Time limit: M06)
	05.04.2004	Reply to a communication from the examining division
	21.05.2004	Despatch of a communication from the examining division (Time limit: M06)
	22.11.2004	Reply to a communication from the examining division
	29.04.2005	Despatch of a communication from the examining division (Time limit: M06)
	19.10.2005	Reply to a communication from the examining division
	21.02.2006	Communication of intention to grant the patent
	04.07.2006	Application deemed to be withdrawn, date of legal effect [2007/02]
	09.08.2006	Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2007/02]
Fees paid	Renewal fee
	28.02.2001	Renewal fee patent year 03
	08.03.2002	Renewal fee patent year 04
	21.02.2003	Renewal fee patent year 05
	25.03.2004	Renewal fee patent year 06
	22.03.2005	Renewal fee patent year 07
	29.03.2006	Renewal fee patent year 08
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[A]WO9611269 (REGENERON PHARMA [US], et al) [A] 1-26 * figure 6 *;
		[E]WO9915654 (GENENTECH INC [US], et al) [E] 1,3-8,10-22,25 * SEQ ID NOs 1,2; page 33, line 1 - page 36, line 16; figures 2,3; examples 9-14 *;
		[E]WO9932515 (ZYMOGENETICS INC [US]) [E] 1,3-8,10-22,25 * SEQ ID NOs 1,2 *;
		[X] - HILLIER L. ET AL., "yw93f11.r1 Soares_placenta_8to9weeks_2NbHP8to9W Homo sapiens cDNA clone.", EMBL, (19960229), Database accession no. N57259, URL: EBI, XP002217323 [X] 1,3,18 * abstract *
		[T] - KIM I ET AL, "HEPATIC EXPRESSION, SYNTHESIS AND SECRETION OF A NOVEL FIBRINOGEN/ANGIOPOIETIN-RELATED PROTEIN THAT PREVENTS ENDOTHELIAL-CELL APOPTOSIS", BIOCHEMICAL JOURNAL, THE BIOCHEMICAL SOCIETY, LONDON, GB, (20000315), vol. 346, no. 3, ISSN 0264-6021, pages 603 - 610, XP000971125 [T] * figure 5 * DOI: http://dx.doi.org/10.1042/0264-6021:3460603
		[T] - KERSTEN SANDER ET AL, "Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene.", JOURNAL OF BIOLOGICAL CHEMISTRY, (20000915), vol. 275, no. 37, ISSN 0021-9258, pages 28488 - 28493, XP002217322 [T] * figure 6 * DOI: http://dx.doi.org/10.1074/jbc.M004029200
	International search	[A] - MATSUSHITA M, ET AL., "A NOVEL HUMAN SERUM LECTIN WITH COLLAGEN- AND FIBRINOGEN-LIKE DOMAINS THAT FUNCTIONS AS AN OPSONIN", Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, US, US, (19960202), vol. 271, no. 05, doi:10.1074/jbc.271.23.13770, ISSN 0021-9258, pages 2448 - 2454, XP002918842 DOI: http://dx.doi.org/10.1074/jbc.271.23.13770
		[A] - ICHIJO H, ET AL., "MOLECULAR CLONING AND CHARACTERIZATION OF FICOLIN, A MULTIMERIC PROTEIN WITH FIBRINOGEN- AND COLLAGEN-LIKE DOMAINS", Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, US, US, (19930705), vol. 269, no. 19, ISSN 0021-9258, pages 14505 - 14513, XP002918843
		[A] - LE Y, ET AL., "PURIFICATION AND BINDING PROPERTIES OF A HUMAN FICOLIN-LIKE PROTEIN", JOURNAL OF IMMUNOLOGICAL METHODS., ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM., NL, NL, (19970101), vol. 204, doi:10.1016/S0022-1759(97)00029-X, ISSN 0022-1759, pages 43 - 49, XP002918844 DOI: http://dx.doi.org/10.1016/S0022-1759(97)00029-X

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p